EducationExperience

• 2012–2016,Ph.D.Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden.Supervisor: Chunyan Zhao,Associate Professor. Co-supervisor: Karin Dahlman-Wright, Professor.

• 2009-2011,M.D.School of Public Health, Jilin University, Changchun, China.

• 2004-2009, B.S.Clinical Laboratory Medicine, Beihua University, Jilin, China.

Working Experience

• 2016-present:Associate Professor inSchool of Public Health, Jilin University

Research Fields

• To comprehensively decipher the role of transcription factor AP-1 in triple-negative breast cancer and hormone-therapy resistance patients, using functional genomics technologies that can survey the cistrome, transcriptome and proteome at an unprecedented detail.

• To determine genetic variants associated with prognosis of breast cancer.

• To identify novel breast-tumor specific markers for disease progression.

• To study the long-term breast cancer prognosis as well as the panorama of diseases in breast cancer survivors.

Research Projects

• 2017-2018,Science Technology Department of Jilin Province, 80,000 RMB.

• 2018-2019,TheEducation Department of Jilin Province, 25,000RMB.

• 2018-2020,National Natural Science Foundation of China (NSFC), 200,000RMB

• 2018-2020,Science Technology Department of Jilin Province, 150,000RMB

• 2018-2020,Health and Family Planning Commission of Jilin Province, 20,000RMB.

• 2021-2023,Jilin University, 50,000RMB

Publications

• Sainan Liu, Bin Liu, Qian Zhao, Jikang Shi, Yulu Gu, Yanbo Guo, Yong Li, Yunkai Liu, Yi Cheng,Yichun Qiao*,Yawen Liu*.Down-regulated FST Expression is Involved in the Poor Prognosis of Triple-negative Breast Cancer.Cancer Cell International2021

• Qian Zhao,Kaixin Zhang, Yong Li, Yaxuan Ren, Jikang Shi, Yulu Gu, Shuang Qiu, Sainan Liu, Yi Cheng,Yichun Qiao*,Yawen Liu*.OLFML2A is Necessary for Anti-triple Negative Breast Cancer Effect of Selective Activator Protein-1 Inhibitor T-5224.Translational Oncology2021.

• Shuang Qiu, Yuping Lu, Yan Li, Jikang Shi, Heran Cui, Yulu Gu, Yong Li, Weijing Zhong, Xiaojuan Zhu, Yunkai Liu, Yi Cheng, Yawen Liu,Yichun Qiao*.Prevalence of autism spectrum disorder in Asia: A systematic review and meta-analysis.Psychiatry Res. 2020 Feb;284:112679.

• Shuang Qiu, Yan Li, Ye Bai, Jikang Shi, Heran Cui, Yulu Gu, Yaxuan Ren, Qian Zhao, Kaixin Zhang, Meihan Lu, Yihan Wang, Yong Li, Weijing Zhong, Xiaojuan Zhu, Yunkai Liu, Yi Cheng,Yichun Qiao*, Yawen Liu*.SHANK1 polymorphisms and SNP-SNP interactions among SHANK family: A possible cue for recognition to autism spectrum disorder in infant age.Autism Res. 2019 12(3):375-383.

• Yichun Qiao, Huan He, Philip Jonsson, Indranil Sinha, Chunyan Zhao, Karin Dahlman-Wright. AP-1 Is a Key Regulator of Proinflammatory Cytokine TNFα-mediated Triple-negative Breast Cancer Progression.J Biol Chem. 2016 291(10):5068-5079.

• Chunyan Zhao,Yichun Qiao, Philip Jonsson, Jian Wang, Li Xu, Pegah Rouhi, Indranil Sinha, Yihai Cao, Cecilia Williams, Karin Dahlman-Wright. Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer.Cancer Res. 2014 74(14):3983-3994.

• Karin Dahlman-Wright,Yichun Qiao, Philip Jonsson, Jan-Åke Gustafsson, Cecilia Williams, Chunyan Zhao. Interplay between AP-1 and estrogen receptor α in regulating gene expression and proliferation networks in breast cancer cells.Carcinogenesis. 2012 33(9):1684-1691.